response to antineoplastic agent

Definition

Target type: biologicalprocess

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antineoplastic agent stimulus. An antineoplastic agent is a substance that inhibits or prevents the proliferation of neoplasms. [GOC:pr]

Response to antineoplastic agent is a complex biological process that involves a variety of cellular and molecular mechanisms. Antineoplastic agents, also known as anticancer drugs, are designed to target and inhibit the growth and proliferation of cancer cells. The mechanisms of action of antineoplastic agents vary widely, but they can broadly be classified into several categories:

**1. DNA Damage and Replication Inhibition:**
- Alkylating agents, such as cyclophosphamide and cisplatin, damage DNA by adding alkyl groups, disrupting its structure and preventing DNA replication.
- Topoisomerase inhibitors, like etoposide and doxorubicin, interfere with the enzymes that regulate DNA topology, leading to DNA breaks and cell death.
- Antimetabolites, such as methotrexate and 5-fluorouracil, mimic natural metabolites and interfere with DNA synthesis and repair pathways.

**2. Microtubule Disruption:**
- Microtubule-targeting agents, like vincristine and paclitaxel, bind to and stabilize or destabilize microtubules, disrupting the cell cycle and preventing cell division.

**3. Signal Transduction Inhibition:**
- Tyrosine kinase inhibitors, such as imatinib and erlotinib, target specific signaling pathways that promote cancer cell growth and survival.
- Monoclonal antibodies, like trastuzumab and rituximab, bind to specific targets on cancer cells, triggering their destruction or blocking their growth signals.

**4. Cell Cycle Arrest:**
- Some antineoplastic agents, such as cytarabine and gemcitabine, induce cell cycle arrest at specific checkpoints, preventing cell division and promoting apoptosis.

**5. Induction of Apoptosis (Programmed Cell Death):**
- Certain antineoplastic agents, such as TRAIL and TNF-alpha, trigger apoptosis pathways, leading to the controlled destruction of cancer cells.

**6. Immune System Modulation:**
- Immunotherapies, such as checkpoint inhibitors (e.g., ipilimumab, nivolumab), stimulate the immune system to recognize and destroy cancer cells.

The response to antineoplastic agents is influenced by a variety of factors, including the type of cancer, the stage of the disease, the patient's overall health, and the specific drug regimen. Some individuals may experience a complete response to treatment, while others may experience a partial response or no response at all. The effectiveness of antineoplastic agents can also be affected by the development of drug resistance, where cancer cells evolve mechanisms to evade the drug's effects.

It is important to note that the biological process of response to antineoplastic agent is a complex and dynamic phenomenon. Ongoing research continues to elucidate the intricate mechanisms involved and explore novel strategies for improving the effectiveness and reducing the side effects of anticancer therapies.'
"

Proteins (1)

Compounds (4)